Virtus ETF Advisers LLC - RECURSION PHARMACEUTICALS IN ownership

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 144 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of RECURSION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$76,745
-6.8%
10,032
-9.0%
0.05%
-4.1%
Q2 2023$82,379
+11.4%
11,028
-0.5%
0.05%
+19.5%
Q1 2023$73,937
-37.5%
11,085
-27.7%
0.04%
-33.9%
Q4 2022$118,287
-33.9%
15,342
-8.9%
0.06%
-12.7%
Q3 2022$179,000
+31.6%
16,847
+0.7%
0.07%
+42.0%
Q2 2022$136,000
+126.7%
16,726
+101.0%
0.05%
+85.2%
Q1 2022$60,000
-60.3%
8,321
-5.7%
0.03%
-52.6%
Q4 2021$151,0008,8210.06%
Other shareholders
RECURSION PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
Kinnevik AB (publ) 10,405,668$77,730,340100.00%
Data Collective IV GP, LLC 5,941,120$44,380,16632.86%
MV Management XI, L.L.C. 1,971,908$14,730,15325.77%
MIC Capital Management UK LLP 8,451,758$63,134,63512.84%
Yong Rong (HK) Asset Management Ltd 1,174,200$8,7723.85%
ArchPoint Investors 1,114,626$8,326,2563.22%
PLATINUM INVESTMENT MANAGEMENT LTD 2,711,148$20,252,2760.70%
HARVARD MANAGEMENT CO INC 882,129$6,5900.65%
Diametric Capital, LP 119,906$895,6980.40%
Lingotto Investment Management LLP 775,077$5,789,8250.37%
View complete list of RECURSION PHARMACEUTICALS IN shareholders